Bitcoin mining company Cango received a notification letter from the New York Stock Exchange indicating that it has failed to meet the continued listing price standards.

BlockBeatNews

BlockBeats message, April 1, according to a report by PR Newswire, Bitcoin mining company Cango Inc. (NYSE: CANG) received a notice letter from the New York Stock Exchange (NYSE), informing it that it failed to meet the NYSE’s continued listing price requirements. As of March 9, 2026, the average closing price of Cango Class A ordinary shares for 30 consecutive trading days was below $1.00 per share, which does not comply with the requirements of Rule 802.01C of the NYSE listing rules.

Under the rules, Cango has a 6-month cure period from the date it received the notice. If, in any natural month during the cure period, the last trading day’s closing price and the average closing price for the preceding 30 trading days are both not less than $1.00, compliance can be restored.

Cango said the company has notified the NYSE of its intention to cure and will continue to assess market conditions and feasible solutions. During the cure period, Cango’s Class A ordinary shares will continue to trade normally on the NYSE. This notice does not affect the company’s day-to-day operations, its filing obligations with the U.S. Securities and Exchange Commission (SEC), or other contractual obligations.

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Comment
0/400
No comments